Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

The Oxygen and Sulfide Binding Characteristics of Hemoglobins Generated from Methemoglobin by Two Erythrocytic Systems

ROGER P. SMITH
Molecular Pharmacology July 1967, 3 (4) 378-385;
ROGER P. SMITH
Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire 03755
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Methemoglobinemia induced in mice and other animals protects against death from inhaled hydrogen sulfide or injected sodium sulfide. Equivalent circulating levels of methemoglobin impart equivalent degrees of protection irrespective of the agent used to induce the methemoglobinemia (nitrite, p-aminopropiophenone, or hydroxylamine). In each case 2-4 moles of sulfide are apparently inactivated in vivo for each available ferric heme group. The ferric iron of methemoglobin is one site available for hydrosulfide anion binding. No information is available about the nature of the additional sulfide binding sites, but they are inferred to be associated with the globin moiety.

Protection against sulfide poisoning is not demonstrable in mice after methemoglobin levels have been reduced to normal concentrations by spontaneous methemoglobin reductase activity. However, if methemoglobin reductase activity is increased by methylene blue, a ferrous hemoglobin which retains significant sulfide-inactivating properties exists transiently in vivo. This protective effect is also lost after a time interval equivalent to that required for spontaneous activity to reduce methemoglobin levels to normal in the absence of methylene blue. In mouse erythrocytes exposed to sodium nitrite the nonmethemoglobin heme produced as a result of methylene blue-induced reductase activity has only one-tenth of the oxygen capacity of normal mouse hemoglobin or the product of normal mouse methemoglobin reductase activity. A fully functional mouse hemoglobin in terms of its oxygen capacity is eventually generated in the presence of both methylene blue and nitrite if enough time is allowed for the spontaneous reductase to act. Similarly, the total ferrous hemoglobin products of methylene blue-induced reductase activity in nitrited human cells have less than half the oxygen-binding capacity of normal human hemoglobin. These findings suggest that spontaneous reductase activity restores a fully functional hemoglobin whereas methylene blue-induced reductase activity only reduces the heme iron. The methylene blue therapy of methemoglobinemia bears reexamination in terms of these findings.

ACKNOWLEDGMENTS These studies were supported in part by Research Grant AP 00260, Division of Air Pollution, USPHS. We are grateful to Professor G. E. Likens, Department of Biological Sciences, Dartmouth College, for allowing us use of his atomic absorption spectrophotometer. Mrs. Jean Williams assisted in many of these experiments.

  • Copyright ©, 1967, by Academic Press Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 3, Issue 4
1 Jul 1967
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Oxygen and Sulfide Binding Characteristics of Hemoglobins Generated from Methemoglobin by Two Erythrocytic Systems
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The Oxygen and Sulfide Binding Characteristics of Hemoglobins Generated from Methemoglobin by Two Erythrocytic Systems

ROGER P. SMITH
Molecular Pharmacology July 1, 1967, 3 (4) 378-385;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

The Oxygen and Sulfide Binding Characteristics of Hemoglobins Generated from Methemoglobin by Two Erythrocytic Systems

ROGER P. SMITH
Molecular Pharmacology July 1, 1967, 3 (4) 378-385;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Anti-aromatase activity of exemestane phase II metabolites
  • α-Conotoxin Binding Site on the GABAB Receptor
  • Upacicalcet binds to the amino acid binding site of CaSR
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics